Should you buy Divi's Labs, Zomato, CreditAccess Grameen, other largecap stocks?
Here's what global brokerages' analysts make of stocks such as Divi's Laboratories, Zomato, and Kalyan Jewellers.
As Dalal Street enters the November 2024 month's last session, analysts from global brokerages have handpicked several stocks on the basis of their research.
Global Brokerage Stock Recommendations
Here's what Goldman Sachs, Jefferies, Citi, Nomura, BofA, and Bernstein make of stocks such as Divis Labs, Zomato, Kalyan and Jewellers.
Midcap Stock | CreditAccess Grameen shares
CreditAccess Grameen Share Price Target: Goldman Sachs has a 'sell' call on CreditAccess Grameen shares with a target of Rs 564.
CreditAccess Grameen shares
CreditAccess Grameen Shares Price Target: Nomura has maintained a 'reduce' rating on CreditAccess Grameen shares with a target of Rs 850.
Largecap Stock | Zomato shares
Zomato Share Price Target: Jefferies has maintained a 'buy' call on Zomato shares with a target of Rs 335.
Largecap Stock | L&T Finance shares
L&T Finance Shares Price Target: Goldman Sachs has maintained a 'buy' call on L&T Finance shares with a target of Rs 193.
Largecap Stock | PB Fintech shares
PB Fintech Shares Price Target: Bernstein has maintained an 'outperform' rating on PB Fintech shares with a target of Rs 1,720.
Largecap Stock | PB Fintech shares
PB Fintech Shares Price Target: BofA has maintained a 'neutral' rating on the PB Fintech stock with a target of Rs 1,850.
Largecap Stock | Divi's Laboratories shares
Divi's Laboratories Share Price Target: Citi has maintained a 'buy' call on Divi's Laboratories shares with a target of Rs 6,850.
Largecap Stock | Kalyan Jewellers shares
Kalyan Jewellers Share Price Target: Citi has maintained a 'buy' call on Kalyan Jewellers shares with a target of Rs 810.